Improving Medication Use. Advancing Patient Care.

APhA is the leading advocate for the pharmacy profession

Offering quality education, practice tools, and resources to help you reach your full potential as a patient care provider

Learn more

News View all news

April 24, 2019

For first time, pharmaceutical distributor faces federal criminal charges over opioid crisis

Federal prosecutors on Tuesday charged Rochester Drug Cooperative (RDC) as a corporate entity with conspiring to distribute drugs, conspiracy to defraud the United States, and failing to file suspicious order reports. To settle the civil and criminal charges brought by the Manhattan U.S. attorney's office, RDC has agreed to pay a $20 million fine.

April 23, 2019

Adherence to heart medications plummets with pharmacy closures

Pharmacy closures have a significant impact on adherence to essential heart medications among older U.S. adults, according to a new study published in JAMA Network Open on April 19.

April 23, 2019

Coalition of drug supply chain members welcomes pharmacist feedback on track-and-trace proposal

The November 2023 deadline for full implementation of the Drug Supply Chain Security Act (DSCSA) looms large, but many of the specifics are far from determined. DSCSA, also known as “track and trace,” mandates that all members of the U.S. supply chain—including pharmacies—use an interoperable electronic system that tracks a drug at the package level until it reaches the pharmacy. The policy is aimed at protecting consumers from counterfeit, stolen, contaminated, or otherwise harmful drugs, including through improved recall processes.

April 23, 2019

FDA expresses continued confidence in the safety and effectiveness of MMR vaccine

With an increasing number of measles outbreaks across the country and around the world, FDA is stressing its continued confidence in the measles, mumps, and rubella (MMR) vaccine. CDC has reported that outbreaks of mumps have also been reported in the United States this year.

April 22, 2019

FDA approves first generic naloxone nasal spray to treat opioid overdose

FDA on Friday gave final approval of the first generic naloxone hydrochloride nasal spray (Teva Pharmaceuticals USA). The agency gave tentative approval to this generic drug product in June 2018.

Students

Let APhA help you through your pharmacy training and beyond.

Learn More

New Practitioners

Your career starts here. Get the tools you need to kick-start your career.

Learn More

Pharmacists

Reach your full potential as a pharmacist with these helpful practice tools and resources.

Learn More

Pharmacy Technicians

Media/Press

Not a member? See What APhA can do for you

CEO Blog

by Thomas E. Menighan

View all CEO blog posts

April 9, 2019

What’s the right treatment plan for pharmacist workforce supply…

Imbalances between workforce supply and demand are notoriously difficult to resolve. Market corrections can take decades to work themselves out, and leaving the market to self-correct doesn’t help…

Safety in the pharmacy: Continuing the dialogue

You may have noticed a resurgence recently of the online dialogue about the safety of pharmacists in the workplace, particularly after a pharmacist and technician were shot and wounded at their…

Press Releases

View all press releases

March 29, 2019

APhA2019: Moving Pharmacy Forward

The American Pharmacists Association (APhA) Annual Meeting & Exposition, APhA2019, held March 22–25, hosted almost 6,000 pharmacists and student pharmacists in Seattle. This year’s theme, Moving Pharmacy Forward, highlighted the pharmacist’s role in addressing public health concerns and promoted personal and professional well-being while continuing to prioritize patient care services.

March 11, 2019

APhA Partners with iForumRx.org on New Line of Ambulatory Care Recertification Tools

The American Pharmacists Association (APhA) announced a partnership with iForumRx.org, an interactive web-based community for ambulatory care pharmacy specialists, to produce a new line of recertification tools centered around podcasts, panel discussions, and polls.

Why APhA?

APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.